Private demand for cholera vaccines in Beira, Mozambique

Abstract In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members. Respondents were told that two doses of the vaccine would be required 2 weeks apar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2007-03, Vol.25 (14), p.2599-2609
Hauptverfasser: Lucas, Marcelino E.S, Jeuland, Marc, Deen, Jacqueline, Lazaro, Nivalda, MacMahon, Melissa, Nyamete, Andrew, Barreto, Avertino, von Seidlein, Lorenz, Cumbane, Arnaldo, Songane, Francisco F, Whittington, Dale
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2609
container_issue 14
container_start_page 2599
container_title Vaccine
container_volume 25
creator Lucas, Marcelino E.S
Jeuland, Marc
Deen, Jacqueline
Lazaro, Nivalda
MacMahon, Melissa
Nyamete, Andrew
Barreto, Avertino
von Seidlein, Lorenz
Cumbane, Arnaldo
Songane, Francisco F
Whittington, Dale
description Abstract In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members. Respondents were told that two doses of the vaccine would be required 2 weeks apart, and that the cholera vaccine would offer excellent protection against infection for the first year following vaccination, and some protection during the second and third year after a person is vaccinated. This research was carried out in order to learn more about private demand for vaccines in a cholera-endemic area. We asked two types of valuation questions: (1) a discrete-price offer for a vaccine that could be purchased for household members and (2) a payment card designed to assess uncertainty in the respondent's demand for a vaccine for self-protection. We estimate average household willingness to pay (WTP) for cholera vaccines in Beira to be 2005 US$ 8.45. This estimate of household WTP represents the perceived private economic benefits to a household – six persons on average – of giving all members free cholera vaccines.
doi_str_mv 10.1016/j.vaccine.2006.12.027
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70288495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X06013612</els_id><sourcerecordid>20309788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-fb0563bc0238a758a17170f9706d5ae18a3799155ecb239d80f9a7a048dfb7683</originalsourceid><addsrcrecordid>eNqFkVuLFDEQhYMo7rj6E5QGcZ_stirpXPplxV28wYqCCvsW0ulqzNiXNZkZWH-9GadhYF_2KQ_11Tk5dRh7jlAhoHqzrnbO-zBRxQFUhbwCrh-wFRotSi7RPGQr4Koua4TrE_YkpTUASIHNY3aCmktj6nrFzLcYdm5DRUejm7qin2Phf80DRVcsBqkIU3FBIbrXxZf5rxvb8GdLT9mj3g2Jni3vKfv54f2Py0_l1dePny_fXZVegt6UfQtSidYDF8ZpaRxq1NA3GlQnHaFxQjcNSkm-5aLpTJ457aA2Xd9qZcQpOzvo3sQ526aNHUPyNAxuonmbrAaekzTyXpCDgEabveLLO-B63sYph7Aoa41KSqgzJQ-Uj3NKkXp7E8Po4q1FsPsG7NouB7L7BixymxvIey8W9W07UnfcWk6egVcL4JJ3Qx_d5EM6ckbl1mrM3NsDR_m6u0DRJh9o8tSFSH5juznc-5XzOwp-CFPIpr_pltIxtU15wX6H_8ZwDQpQKOTiH4bGuIM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547165504</pqid></control><display><type>article</type><title>Private demand for cholera vaccines in Beira, Mozambique</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central</source><creator>Lucas, Marcelino E.S ; Jeuland, Marc ; Deen, Jacqueline ; Lazaro, Nivalda ; MacMahon, Melissa ; Nyamete, Andrew ; Barreto, Avertino ; von Seidlein, Lorenz ; Cumbane, Arnaldo ; Songane, Francisco F ; Whittington, Dale</creator><creatorcontrib>Lucas, Marcelino E.S ; Jeuland, Marc ; Deen, Jacqueline ; Lazaro, Nivalda ; MacMahon, Melissa ; Nyamete, Andrew ; Barreto, Avertino ; von Seidlein, Lorenz ; Cumbane, Arnaldo ; Songane, Francisco F ; Whittington, Dale</creatorcontrib><description>Abstract In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members. Respondents were told that two doses of the vaccine would be required 2 weeks apart, and that the cholera vaccine would offer excellent protection against infection for the first year following vaccination, and some protection during the second and third year after a person is vaccinated. This research was carried out in order to learn more about private demand for vaccines in a cholera-endemic area. We asked two types of valuation questions: (1) a discrete-price offer for a vaccine that could be purchased for household members and (2) a payment card designed to assess uncertainty in the respondent's demand for a vaccine for self-protection. We estimate average household willingness to pay (WTP) for cholera vaccines in Beira to be 2005 US$ 8.45. This estimate of household WTP represents the perceived private economic benefits to a household – six persons on average – of giving all members free cholera vaccines.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2006.12.027</identifier><identifier>PMID: 17258844</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Applied microbiology ; Bacterial diseases ; Bacteriology ; Biological and medical sciences ; Cholera ; Cholera Vaccines - administration &amp; dosage ; Cholera Vaccines - economics ; Contingent valuation method ; Costs and Cost Analysis ; Fundamental and applied biological sciences. Psychology ; Households ; Human bacterial diseases ; Humans ; Immunization ; Infectious diseases ; Medical sciences ; Microbiology ; Miscellaneous ; Mozambique ; Studies ; Tropical bacterial diseases ; Vaccination - economics ; Vaccine demand ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Waterborne diseases ; Willingness to pay</subject><ispartof>Vaccine, 2007-03, Vol.25 (14), p.2599-2609</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited Mar 30, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-fb0563bc0238a758a17170f9706d5ae18a3799155ecb239d80f9a7a048dfb7683</citedby><cites>FETCH-LOGICAL-c507t-fb0563bc0238a758a17170f9706d5ae18a3799155ecb239d80f9a7a048dfb7683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1547165504?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18626441$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17258844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lucas, Marcelino E.S</creatorcontrib><creatorcontrib>Jeuland, Marc</creatorcontrib><creatorcontrib>Deen, Jacqueline</creatorcontrib><creatorcontrib>Lazaro, Nivalda</creatorcontrib><creatorcontrib>MacMahon, Melissa</creatorcontrib><creatorcontrib>Nyamete, Andrew</creatorcontrib><creatorcontrib>Barreto, Avertino</creatorcontrib><creatorcontrib>von Seidlein, Lorenz</creatorcontrib><creatorcontrib>Cumbane, Arnaldo</creatorcontrib><creatorcontrib>Songane, Francisco F</creatorcontrib><creatorcontrib>Whittington, Dale</creatorcontrib><title>Private demand for cholera vaccines in Beira, Mozambique</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members. Respondents were told that two doses of the vaccine would be required 2 weeks apart, and that the cholera vaccine would offer excellent protection against infection for the first year following vaccination, and some protection during the second and third year after a person is vaccinated. This research was carried out in order to learn more about private demand for vaccines in a cholera-endemic area. We asked two types of valuation questions: (1) a discrete-price offer for a vaccine that could be purchased for household members and (2) a payment card designed to assess uncertainty in the respondent's demand for a vaccine for self-protection. We estimate average household willingness to pay (WTP) for cholera vaccines in Beira to be 2005 US$ 8.45. This estimate of household WTP represents the perceived private economic benefits to a household – six persons on average – of giving all members free cholera vaccines.</description><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Bacterial diseases</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Cholera</subject><subject>Cholera Vaccines - administration &amp; dosage</subject><subject>Cholera Vaccines - economics</subject><subject>Contingent valuation method</subject><subject>Costs and Cost Analysis</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Households</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Mozambique</subject><subject>Studies</subject><subject>Tropical bacterial diseases</subject><subject>Vaccination - economics</subject><subject>Vaccine demand</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Waterborne diseases</subject><subject>Willingness to pay</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkVuLFDEQhYMo7rj6E5QGcZ_stirpXPplxV28wYqCCvsW0ulqzNiXNZkZWH-9GadhYF_2KQ_11Tk5dRh7jlAhoHqzrnbO-zBRxQFUhbwCrh-wFRotSi7RPGQr4Koua4TrE_YkpTUASIHNY3aCmktj6nrFzLcYdm5DRUejm7qin2Phf80DRVcsBqkIU3FBIbrXxZf5rxvb8GdLT9mj3g2Jni3vKfv54f2Py0_l1dePny_fXZVegt6UfQtSidYDF8ZpaRxq1NA3GlQnHaFxQjcNSkm-5aLpTJ457aA2Xd9qZcQpOzvo3sQ526aNHUPyNAxuonmbrAaekzTyXpCDgEabveLLO-B63sYph7Aoa41KSqgzJQ-Uj3NKkXp7E8Po4q1FsPsG7NouB7L7BixymxvIey8W9W07UnfcWk6egVcL4JJ3Qx_d5EM6ckbl1mrM3NsDR_m6u0DRJh9o8tSFSH5juznc-5XzOwp-CFPIpr_pltIxtU15wX6H_8ZwDQpQKOTiH4bGuIM</recordid><startdate>20070330</startdate><enddate>20070330</enddate><creator>Lucas, Marcelino E.S</creator><creator>Jeuland, Marc</creator><creator>Deen, Jacqueline</creator><creator>Lazaro, Nivalda</creator><creator>MacMahon, Melissa</creator><creator>Nyamete, Andrew</creator><creator>Barreto, Avertino</creator><creator>von Seidlein, Lorenz</creator><creator>Cumbane, Arnaldo</creator><creator>Songane, Francisco F</creator><creator>Whittington, Dale</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20070330</creationdate><title>Private demand for cholera vaccines in Beira, Mozambique</title><author>Lucas, Marcelino E.S ; Jeuland, Marc ; Deen, Jacqueline ; Lazaro, Nivalda ; MacMahon, Melissa ; Nyamete, Andrew ; Barreto, Avertino ; von Seidlein, Lorenz ; Cumbane, Arnaldo ; Songane, Francisco F ; Whittington, Dale</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-fb0563bc0238a758a17170f9706d5ae18a3799155ecb239d80f9a7a048dfb7683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Bacterial diseases</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Cholera</topic><topic>Cholera Vaccines - administration &amp; dosage</topic><topic>Cholera Vaccines - economics</topic><topic>Contingent valuation method</topic><topic>Costs and Cost Analysis</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Households</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Mozambique</topic><topic>Studies</topic><topic>Tropical bacterial diseases</topic><topic>Vaccination - economics</topic><topic>Vaccine demand</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Waterborne diseases</topic><topic>Willingness to pay</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lucas, Marcelino E.S</creatorcontrib><creatorcontrib>Jeuland, Marc</creatorcontrib><creatorcontrib>Deen, Jacqueline</creatorcontrib><creatorcontrib>Lazaro, Nivalda</creatorcontrib><creatorcontrib>MacMahon, Melissa</creatorcontrib><creatorcontrib>Nyamete, Andrew</creatorcontrib><creatorcontrib>Barreto, Avertino</creatorcontrib><creatorcontrib>von Seidlein, Lorenz</creatorcontrib><creatorcontrib>Cumbane, Arnaldo</creatorcontrib><creatorcontrib>Songane, Francisco F</creatorcontrib><creatorcontrib>Whittington, Dale</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest_Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lucas, Marcelino E.S</au><au>Jeuland, Marc</au><au>Deen, Jacqueline</au><au>Lazaro, Nivalda</au><au>MacMahon, Melissa</au><au>Nyamete, Andrew</au><au>Barreto, Avertino</au><au>von Seidlein, Lorenz</au><au>Cumbane, Arnaldo</au><au>Songane, Francisco F</au><au>Whittington, Dale</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Private demand for cholera vaccines in Beira, Mozambique</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2007-03-30</date><risdate>2007</risdate><volume>25</volume><issue>14</issue><spage>2599</spage><epage>2609</epage><pages>2599-2609</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members. Respondents were told that two doses of the vaccine would be required 2 weeks apart, and that the cholera vaccine would offer excellent protection against infection for the first year following vaccination, and some protection during the second and third year after a person is vaccinated. This research was carried out in order to learn more about private demand for vaccines in a cholera-endemic area. We asked two types of valuation questions: (1) a discrete-price offer for a vaccine that could be purchased for household members and (2) a payment card designed to assess uncertainty in the respondent's demand for a vaccine for self-protection. We estimate average household willingness to pay (WTP) for cholera vaccines in Beira to be 2005 US$ 8.45. This estimate of household WTP represents the perceived private economic benefits to a household – six persons on average – of giving all members free cholera vaccines.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17258844</pmid><doi>10.1016/j.vaccine.2006.12.027</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2007-03, Vol.25 (14), p.2599-2609
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_70288495
source MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central
subjects Allergy and Immunology
Applied microbiology
Bacterial diseases
Bacteriology
Biological and medical sciences
Cholera
Cholera Vaccines - administration & dosage
Cholera Vaccines - economics
Contingent valuation method
Costs and Cost Analysis
Fundamental and applied biological sciences. Psychology
Households
Human bacterial diseases
Humans
Immunization
Infectious diseases
Medical sciences
Microbiology
Miscellaneous
Mozambique
Studies
Tropical bacterial diseases
Vaccination - economics
Vaccine demand
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Waterborne diseases
Willingness to pay
title Private demand for cholera vaccines in Beira, Mozambique
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A41%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Private%20demand%20for%20cholera%20vaccines%20in%20Beira,%20Mozambique&rft.jtitle=Vaccine&rft.au=Lucas,%20Marcelino%20E.S&rft.date=2007-03-30&rft.volume=25&rft.issue=14&rft.spage=2599&rft.epage=2609&rft.pages=2599-2609&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2006.12.027&rft_dat=%3Cproquest_cross%3E20309788%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547165504&rft_id=info:pmid/17258844&rft_els_id=S0264410X06013612&rfr_iscdi=true